跳至主要内容
临床试验/CTRI/2022/09/045377
CTRI/2022/09/045377尚未招募2 期

Efficacy and safety of Curcuma longa as an add on therapy with CAPOX regimen in patients with metastatic colorectal cancer - a randomized double blind placebo controlled trial

JIPMER Intramural fund0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient of age >18 years of age, diagnosed de novo or recurrent metastatic colorectal cancer and planned to be started with first-line CAPOX regimen, ECOG performance status <2

排除标准

  • Patients with human immunodeficiency virus, hepatitis B, or Hepatitis C infection
  • Pregnant or lactating women
  • Impaired renal function defined as creatinine >1.5 mg/dl Upper normal limit (UNL)
  • Impaired hematological function defined by ANC <1.5 L; platelet count ââ?°Â¤ 100Ã?â??109/L, hemoglobin ââ?°Â¤ 9 g/dl
  • Impaired liver function is defined as AST & ALT ââ?°Â¥ 2.5 Ã?â?? UNL, total serum bilirubin ââ?°Â¥1.5 UNL, Alkaline phosphatase ââ?°Â¥ 2.5 Ã?â?? UNL
  • Significant cardiovascular disease defined as LVEF < 50%/ myocardial infarction/stroke within the last 6 months, NYHA Class ââ?°Â¥ 3 heart failure, history of QT prolongation

研究者

发起方
JIPMER Intramural fund

相似试验

Effect of turmeric extract in patients with colon... | 临床试验